PRAX

PRAX R&D Expense Growth

75.26%Fiscal year

Period ending:

PRAX FY R&D Growth (YoY)%
PRAX FY R&D Growth (YoY)192.75%-69.41%
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

PRAX r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Praxis Precision Medicines Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
75.2574%
75.6598%
-44.0364%
28.9239%
167.3804%
52.167%
57.051%
0%

Compare r&d expense growth

All PRAX financial metrics · PRAX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.